Ondansetron-induced migraine-type headache

Canadian Journal of Anesthesia

Volumn 57, Issue 9, 2010, Pages 872-873

  Singh, Vinodkumar ^a   Sinha, Ayush ^b   Prakash, Navin ^c  

^a WEST SUFFOLK HOSPITAL   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c PETERBOROUGH CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; DEXAMETHASONE; ONDANSETRON;

ADULT; ANESTHESIA; CASE REPORT; CHEMICALLY INDUCED DISORDER; DEBRIDEMENT; FEMALE; HOSPITALIZATION; HUMAN; METHODOLOGY; MIGRAINE; NOTE; POSTOPERATIVE NAUSEA AND VOMITING;

ADULT; ANESTHESIA; ANTIEMETICS; DEBRIDEMENT; DEXAMETHASONE; FEMALE; HUMANS; MIGRAINE DISORDERS; ONDANSETRON; POSTOPERATIVE NAUSEA AND VOMITING; SEVERITY OF ILLNESS INDEX;

EID: 79952019614     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-010-9350-0     Document Type: Letter

References (5)

1. Sharma R, Panda A. Ondansetron-induced headache in a parturient mimicking postdural puncture headache. Can J Anesth 2010; 57: 187-8.
2. Tyers MB, Bunce KT, Humphrey PP. Pharmacological and antiemetic properties of ondansetron. Eur J Cancer Clin Oncol 1989; 25: S15-9.
3. Russell D, Kenny GN. 5-HT3 antagonists in postoperative nausea and vomiting. Br J Anaesth 1992; 69: 63S-8S.
4. Ye J, Ponnudurai R, Schaefer R. Ondansetron: a selective 5-HT3 receptor antagonist and its applications in CNS-related disorders. CNS Drug Rev 2001; 7: 199-213. (Pubitemid 32656301)
5. Khan RB. Migraine-type headaches in children receiving chemotherapy and ondansetron. J Child Neurol 2002; 17: 857-8. (Pubitemid 36193082)